» Articles » PMID: 9003777

HPK1, a Hematopoietic Protein Kinase Activating the SAPK/JNK Pathway

Overview
Journal EMBO J
Date 1996 Dec 16
PMID 9003777
Citations 62
Authors
Affiliations
Soon will be listed here.
Abstract

In mammalian cells, a specific stress-activated protein kinase (SAPK/JNK) pathway is activated in response to inflammatory cytokines, injury from heat, chemotherapeutic drugs and UV or ionizing radiation. The mechanisms that link these stimuli to activation of the SAPK/JNK pathway in different tissues remain to be identified. We have developed and applied a PCR-based subtraction strategy to identify novel genes that are differentially expressed at specific developmental points in hematopoiesis. We show that one such gene, hematopoietic progenitor kinase 1 (hpk1), encodes a serine/threonine kinase sharing similarity with the kinase domain of Ste20. HPK1 specifically activates the SAPK/JNK pathway after transfection into COS1 cells, but does not stimulate the p38/RK or mitogen-activated ERK signaling pathways. Activation of SAPK requires a functional HPK1 kinase domain and HPK1 signals via the SH3-containing mixed lineage kinase MLK-3 and the known SAPK activator SEK1. HPK1 therefore provides an example of a cell type-specific input into the SAPK/JNK pathway. The developmental specificity of its expression suggests a potential role in hematopoietic lineage decisions and growth regulation.

Citing Articles

HPK1 kinase inhibitor: a sufficient approach to target HPK1 to modulate T cell activation in cancer immunotherapy compared with degraders.

Wang Q, Zhu X, Li J, Xu S, Wang A, Zhang X Front Immunol. 2025; 16:1449106.

PMID: 39981246 PMC: 11839646. DOI: 10.3389/fimmu.2025.1449106.


An updated review of small-molecule HPK1 kinase inhibitors (2016-present).

Duan Y, Guo Z, Zhong W, Chen J, Xu S, Liu J Future Med Chem. 2024; 16(22):2431-2450.

PMID: 39582317 PMC: 11622775. DOI: 10.1080/17568919.2024.2420630.


Homoharringtonine in the treatment of acute myeloid leukemia: A review.

Shen S, Zhuang H Medicine (Baltimore). 2024; 103(44):e40380.

PMID: 39496012 PMC: 11537654. DOI: 10.1097/MD.0000000000040380.


Mechanisms of resistance to tyrosine kinase inhibitor-targeted therapy and overcoming strategies.

Ou X, Gao G, Habaz I, Wang Y MedComm (2020). 2024; 5(9):e694.

PMID: 39184861 PMC: 11344283. DOI: 10.1002/mco2.694.


HPK1 Dysregulation-Associated NK Cell Dysfunction and Defective Expansion Promotes Metastatic Melanoma Progression.

Choi W, Kwon H, Yi E, Lee H, Kim J, Park H Adv Sci (Weinh). 2024; 11(29):e2400920.

PMID: 38828677 PMC: 11304315. DOI: 10.1002/advs.202400920.


References
1.
Bird T, Kyriakis J, Tyshler L, Gayle M, Milne A, Virca G . Interleukin-1 activates p54 mitogen-activated protein (MAP) kinase/stress-activated protein kinase by a pathway that is independent of p21ras, Raf-1, and MAP kinase kinase. J Biol Chem. 1994; 269(50):31836-44. View

2.
Gallo K, Mark M, Scadden D, Wang Z, Gu Q, Godowski P . Identification and characterization of SPRK, a novel src-homology 3 domain-containing proline-rich kinase with serine/threonine kinase activity. J Biol Chem. 1994; 269(21):15092-100. View

3.
Sanchez I, Hughes R, Mayer B, Yee K, Woodgett J, Avruch J . Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating transcription factor c-Jun. Nature. 1994; 372(6508):794-8. DOI: 10.1038/372794a0. View

4.
Yan M, Dai T, Deak J, Kyriakis J, Zon L, Woodgett J . Activation of stress-activated protein kinase by MEKK1 phosphorylation of its activator SEK1. Nature. 1994; 372(6508):798-800. DOI: 10.1038/372798a0. View

5.
Herskowitz I . MAP kinase pathways in yeast: for mating and more. Cell. 1995; 80(2):187-97. DOI: 10.1016/0092-8674(95)90402-6. View